カテゴリー： GlobalInfoResearch, 世界

女性医療用医薬品の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Women's Health Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9100772）・商品コード：GIR9100772
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月5日（※2024年版があります。お問い合わせください）
・ページ数：118
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、女性医療用医薬品の世界市場について調べ、まとめました。種類別セグメントは、閉経後骨粗鬆症治療薬、不妊治療薬、子宮内膜症治療薬、避妊薬、閉経治療薬、多嚢胞性卵巣症候群治療薬、その他等、用途別セグメントは、リトルガールズ、若い女性、高齢者の女性等に区分しました。女性医療用医薬品の世界市場概観、メーカー動向、メーカー別女性医療用医薬品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・女性医療用医薬品の市場概観
・女性医療用医薬品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・女性医療用医薬品の企業別販売動向、市場シェア、市場集中度、競争動向
・女性医療用医薬品の世界市場規模
・女性医療用医薬品の北米市場分析（アメリカ、カナダ、メキシコ等）
・女性医療用医薬品のアメリカ市場規模推移
・女性医療用医薬品のカナダ市場規模推移
・女性医療用医薬品のメキシコ市場規模推移
・女性医療用医薬品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・女性医療用医薬品のドイツ市場規模推移
・女性医療用医薬品のイギリス市場規模推移
・女性医療用医薬品のロシア市場規模推移
・女性医療用医薬品のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・女性医療用医薬品の日本市場規模推移
・女性医療用医薬品の中国市場規模推移
・女性医療用医薬品の韓国市場規模推移
・女性医療用医薬品のインド市場規模推移
・女性医療用医薬品の東南アジア市場規模推移
・女性医療用医薬品の南米市場分析（ブラジル、アルゼンチン等）
・女性医療用医薬品の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・女性医療用医薬品の種類別分析/販売量、売上、市場シェア（閉経後骨粗鬆症治療薬、不妊治療薬、子宮内膜症治療薬、避妊薬、閉経治療薬、多嚢胞性卵巣症候群治療薬、その他）
・女性医療用医薬品の用途別分析/市場規模（リトルガールズ、若い女性、高齢者の女性）
・女性医療用医薬品の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・女性医療用医薬品の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Women’s health drug is the health drug specifically for women.

Scope of the Report:
The worldwide market for Women’s Health Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Women’s Health Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
AbbVie Inc
Allergan Plc
Bayer AG
GlaxoSmithKline
Merck & Co.
Pfizer
Therapeutics MD

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Postmenopausal Osteoporosis Drug
Infertility Drug
Endometriosis Drug
Contraceptives Drug
Menopause Drug
Polycystic Ovary Syndrome Drug
Other

Market Segment by Applications, can be divided into
Little Girls
Young Women
Elderly Women

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Women’s Health Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Women’s Health Drugs, with price, sales, revenue and global market share of Women’s Health Drugs in 2017 and 2018.
Chapter 3, the Women’s Health Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Women’s Health Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Women’s Health Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Women’s Health Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Women’s Health Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Postmenopausal Osteoporosis Drug
1.2.2 Infertility Drug
1.2.3 Endometriosis Drug
1.2.4 Contraceptives Drug
1.2.5 Menopause Drug
1.2.6 Polycystic Ovary Syndrome Drug
1.2.7 Other
1.3 Market Analysis by Applications
1.3.1 Little Girls
1.3.2 Young Women
1.3.3 Elderly Women
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie Inc
2.1.1 Business Overview
2.1.2 Women’s Health Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Inc Women’s Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan Plc
2.2.1 Business Overview
2.2.2 Women’s Health Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Plc Women’s Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer AG
2.3.1 Business Overview
2.3.2 Women’s Health Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer AG Women’s Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Women’s Health Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Women’s Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck & Co.
2.5.1 Business Overview
2.5.2 Women’s Health Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck & Co. Women’s Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Women’s Health Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Women’s Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Therapeutics MD
2.7.1 Business Overview
2.7.2 Women’s Health Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Therapeutics MD Women’s Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Women’s Health Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Women’s Health Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Women’s Health Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Women’s Health Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Women’s Health Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Women’s Health Drugs Market Analysis by Regions
4.1 Global Women’s Health Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Women’s Health Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Women’s Health Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Women’s Health Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Women’s Health Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Women’s Health Drugs Sales and Growth Rate (2014-2019)
4.5 South America Women’s Health Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Women’s Health Drugs Sales and Growth Rate (2014-2019)
5 North America Women’s Health Drugs by Country
5.1 North America Women’s Health Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Women’s Health Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Women’s Health Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Women’s Health Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Women’s Health Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Women’s Health Drugs Sales and Growth Rate (2014-2019)
6 Europe Women’s Health Drugs by Country
6.1 Europe Women’s Health Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Women’s Health Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Women’s Health Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Women’s Health Drugs Sales and Growth Rate (2014-2019)
6.3 UK Women’s Health Drugs Sales and Growth Rate (2014-2019)
6.4 France Women’s Health Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Women’s Health Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Women’s Health Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Women’s Health Drugs by Country
7.1 Asia-Pacific Women’s Health Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Women’s Health Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Women’s Health Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Women’s Health Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Women’s Health Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Women’s Health Drugs Sales and Growth Rate (2014-2019)
7.5 India Women’s Health Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Women’s Health Drugs Sales and Growth Rate (2014-2019)
8 South America Women’s Health Drugs by Country
8.1 South America Women’s Health Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Women’s Health Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Women’s Health Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Women’s Health Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Women’s Health Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Women’s Health Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Women’s Health Drugs by Countries
9.1 Middle East and Africa Women’s Health Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Women’s Health Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Women’s Health Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Women’s Health Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Women’s Health Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Women’s Health Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Women’s Health Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Women’s Health Drugs Sales and Growth Rate (2014-2019)
10 Global Women’s Health Drugs Market Segment by Type
10.1 Global Women’s Health Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Women’s Health Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Women’s Health Drugs Revenue and Market Share by Type (2014-2019)
10.2 Postmenopausal Osteoporosis Drug Sales Growth and Price
10.2.1 Global Postmenopausal Osteoporosis Drug Sales Growth (2014-2019)
10.2.2 Global Postmenopausal Osteoporosis Drug Price (2014-2019)
10.3 Infertility Drug Sales Growth and Price
10.3.1 Global Infertility Drug Sales Growth (2014-2019)
10.3.2 Global Infertility Drug Price (2014-2019)
10.4 Endometriosis Drug Sales Growth and Price
10.4.1 Global Endometriosis Drug Sales Growth (2014-2019)
10.4.2 Global Endometriosis Drug Price (2014-2019)
10.5 Contraceptives Drug Sales Growth and Price
10.5.1 Global Contraceptives Drug Sales Growth (2014-2019)
10.5.2 Global Contraceptives Drug Price (2014-2019)
10.6 Menopause Drug Sales Growth and Price
10.6.1 Global Menopause Drug Sales Growth (2014-2019)
10.6.2 Global Menopause Drug Price (2014-2019)
10.7 Polycystic Ovary Syndrome Drug Sales Growth and Price
10.7.1 Global Polycystic Ovary Syndrome Drug Sales Growth (2014-2019)
10.7.2 Global Polycystic Ovary Syndrome Drug Price (2014-2019)
10.8 Other Sales Growth and Price
10.8.1 Global Other Sales Growth (2014-2019)
10.8.2 Global Other Price (2014-2019)
11 Global Women’s Health Drugs Market Segment by Application
11.1 Global Women’s Health Drugs Sales Market Share by Application (2014-2019)
11.2 Little Girls Sales Growth (2014-2019)
11.3 Young Women Sales Growth (2014-2019)
11.4 Elderly Women Sales Growth (2014-2019)
12 Women’s Health Drugs Market Forecast (2019-2024)
12.1 Global Women’s Health Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Women’s Health Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Women’s Health Drugs Market Forecast (2019-2024)
12.2.2 Europe Women’s Health Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Women’s Health Drugs Market Forecast (2019-2024)
12.2.4 South America Women’s Health Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Women’s Health Drugs Market Forecast (2019-2024)
12.3 Women’s Health Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Women’s Health Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Women’s Health Drugs Market Share Forecast by Type (2019-2024)
12.4 Women’s Health Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Women’s Health Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Women’s Health Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Women's Health Drugs Picture
Table Product Specifications of Women's Health Drugs
Figure Global Sales Market Share of Women's Health Drugs by Types in 2018
Table Women's Health Drugs Types for Major Manufacturers
Figure Postmenopausal Osteoporosis Drug Picture
Figure Infertility Drug Picture
Figure Endometriosis Drug Picture
Figure Contraceptives Drug Picture
Figure Menopause Drug Picture
Figure Polycystic Ovary Syndrome Drug Picture
Figure Other Picture
Figure Women's Health Drugs Sales Market Share by Applications in 2018
Figure Little Girls Picture
Figure Young Women Picture
Figure Elderly Women Picture
Figure United States Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Women's Health Drugs Revenue (Value) and Growth Rate (2014-2024)
Table AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table AbbVie Inc Women's Health Drugs Type and Applications
Table AbbVie Inc Women's Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Plc Basic Information, Manufacturing Base and Competitors
Table Allergan Plc Women's Health Drugs Type and Applications
Table Allergan Plc Women's Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Women's Health Drugs Type and Applications
Table Bayer AG Women's Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Women's Health Drugs Type and Applications
Table GlaxoSmithKline Women's Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Women's Health Drugs Type and Applications
Table Merck & Co. Women's Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Women's Health Drugs Type and Applications
Table Pfizer Women's Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Therapeutics MD Basic Information, Manufacturing Base and Competitors
Table Therapeutics MD Women's Health Drugs Type and Applications
Table Therapeutics MD Women's Health Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Women's Health Drugs Sales by Manufacturer (2017-2018)
Figure Global Women's Health Drugs Sales Market Share by Manufacturer in 2017
Figure Global Women's Health Drugs Sales Market Share by Manufacturer in 2018
Table Global Women's Health Drugs Revenue by Manufacturer (2017-2018)
Figure Global Women's Health Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Women's Health Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Women's Health Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Women's Health Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Global Women's Health Drugs Revenue and Growth Rate (2014-2019)
Table Global Women's Health Drugs Sales by Regions (2014-2019)
Table Global Women's Health Drugs Sales Market Share by Regions (2014-2019)
Table Global Women's Health Drugs Revenue by Regions (2014-2019)
Figure Global Women's Health Drugs Revenue Market Share by Regions in 2014
Figure Global Women's Health Drugs Revenue Market Share by Regions in 2018
Figure North America Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Europe Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure South America Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure North America Women's Health Drugs Revenue and Growth Rate (2014-2019)
Table North America Women's Health Drugs Sales by Countries (2014-2019)
Table North America Women's Health Drugs Sales Market Share by Countries (2014-2019)
Figure North America Women's Health Drugs Sales Market Share by Countries in 2014
Figure North America Women's Health Drugs Sales Market Share by Countries in 2018
Table North America Women's Health Drugs Revenue by Countries (2014-2019)
Table North America Women's Health Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Women's Health Drugs Revenue Market Share by Countries in 2014
Figure North America Women's Health Drugs Revenue Market Share by Countries in 2018
Figure United States Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Canada Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Europe Women's Health Drugs Revenue and Growth Rate (2014-2019)
Table Europe Women's Health Drugs Sales by Countries (2014-2019)
Table Europe Women's Health Drugs Sales Market Share by Countries (2014-2019)
Table Europe Women's Health Drugs Revenue by Countries (2014-2019)
Figure Europe Women's Health Drugs Revenue Market Share by Countries in 2017
Figure Europe Women's Health Drugs Revenue Market Share by Countries in 2018
Figure Germany Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure UK Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure France Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Russia Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Italy Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Women's Health Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Women's Health Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Women's Health Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Women's Health Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Women's Health Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Women's Health Drugs Revenue Market Share by Countries 2018
Figure China Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Japan Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Korea Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure India Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure South America Women's Health Drugs Revenue and Growth Rate (2014-2019)
Table South America Women's Health Drugs Sales by Countries (2014-2019)
Table South America Women's Health Drugs Sales Market Share by Countries (2014-2019)
Figure South America Women's Health Drugs Sales Market Share by Countries in 2018
Table South America Women's Health Drugs Revenue by Countries (2014-2019)
Table South America Women's Health Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Women's Health Drugs Revenue Market Share by Countries in 2018
Figure Brazil Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Women's Health Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Women's Health Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Women's Health Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Women's Health Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Women's Health Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Women's Health Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Women's Health Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Women's Health Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure UAE Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Women's Health Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Women's Health Drugs Sales and Growth Rate (2014-2019)
Table Global Women's Health Drugs Sales by Type (2014-2019)
Table Global Women's Health Drugs Sales Share by Type (2014-2019)
Table Global Women's Health Drugs Revenue by Type (2014-2019)
Table Global Women's Health Drugs Revenue Share by Type (2014-2019)
Figure Global Postmenopausal Osteoporosis Drug Sales Growth (2014-2019)
Figure Global Postmenopausal Osteoporosis Drug Price (2014-2019)
Figure Global Infertility Drug Sales Growth (2014-2019)
Figure Global Infertility Drug Price (2014-2019)
Figure Global Endometriosis Drug Sales Growth (2014-2019)
Figure Global Endometriosis Drug Price (2014-2019)
Figure Global Contraceptives Drug Sales Growth (2014-2019)
Figure Global Contraceptives Drug Price (2014-2019)
Figure Global Menopause Drug Sales Growth (2014-2019)
Figure Global Menopause Drug Price (2014-2019)
Figure Global Polycystic Ovary Syndrome Drug Sales Growth (2014-2019)
Figure Global Polycystic Ovary Syndrome Drug Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Women's Health Drugs Sales by Application (2014-2019)
Table Global Women's Health Drugs Sales Share by Application (2014-2019)
Figure Global Young Women Sales Growth (2014-2019)
Figure Global Elderly Women Sales Growth (2014-2019)
Figure Global Women's Health Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Women's Health Drugs Sales Forecast by Regions (2019-2024)
Table Global Women's Health Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Women's Health Drugs Market Forecast (2019-2024)
Figure Europe Sales Women's Health Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Women's Health Drugs Market Forecast (2019-2024)
Figure South America Sales Women's Health Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Women's Health Drugs Market Forecast (2019-2024)
Table Global Women's Health Drugs Sales Forecast by Type (2019-2024)
Table Global Women's Health Drugs Market Share Forecast by Type (2019-2024)
Table Global Women's Health Drugs Sales Forecast by Application (2019-2024)
Table Global Women's Health Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

AbbVie Inc、Allergan Plc、Bayer AG、GlaxoSmithKline、Merck & Co.、Pfizer、Therapeutics MD、

★調査レポート[女性医療用医薬品の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9100772)販売に関する免責事項を必ずご確認ください。
★調査レポート[女性医療用医薬品の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 処方呼吸器薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102928 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、処方呼吸器薬の世界市場について調べ、まとめました。種類別セグメントは、抗炎症薬、マスト安定剤、抗ヒスタミン薬、気管支拡張薬、その他の呼吸器用薬等、用途別セグメントは、病院薬局、ドラッグストア、小売店、ネット販売等に区分しました。処方呼吸器薬の世界市場概観、メーカー動向、メーカー別処方呼吸器薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・処方呼吸器薬の市場概観 ・処方呼吸器薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・処方呼吸器薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・処方呼吸器薬の世界市場規模 ・処方呼吸器薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・処方呼吸器薬のアメリカ市場規模推移 ・処方呼吸器薬のカナダ市場規模推移 ・処方呼吸器薬のメキシコ市場規模推移 ・処方呼吸器薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A prescription drug is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Scope of the Report: The worldwide market for Prescription Respiratory Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prescription Respiratory Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application....
  • アルツハイマー病治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102940 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、アルツハイマー病治療薬の世界市場について調べ、まとめました。種類別セグメントは、コリンエステラーゼ阻害剤、NMDAアンタゴニスト等、用途別セグメントは、ドラッグストア、小売店、その他等に区分しました。アルツハイマー病治療薬の世界市場概観、メーカー動向、メーカー別アルツハイマー病治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アルツハイマー病治療薬の市場概観 ・アルツハイマー病治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アルツハイマー病治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・アルツハイマー病治療薬の世界市場規模 ・アルツハイマー病治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・アルツハイマー病治療薬のアメリカ市場規模推移 ・アルツハイマー病治療薬のカナダ市場規模推移 ・アルツハイマー病治療薬のメキシコ市場規模推移 ・アルツハイマー病治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Scope of the Report: The worldwide market for Alzheimer's Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Alzheimer's Disease Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment...
  • 光感作性薬剤の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101279 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、光感作性薬剤の世界市場について調べ、まとめました。種類別セグメントは、フォトフリン、レヴラン、メトビックス、その他等、用途別セグメントは、腫瘍学、皮膚科、眼科等に区分しました。光感作性薬剤の世界市場概観、メーカー動向、メーカー別光感作性薬剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・光感作性薬剤の市場概観 ・光感作性薬剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・光感作性薬剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・光感作性薬剤の世界市場規模 ・光感作性薬剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・光感作性薬剤のアメリカ市場規模推移 ・光感作性薬剤のカナダ市場規模推移 ・光感作性薬剤のメキシコ市場規模推移 ・光感作性薬剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Photosensitizer Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Photosensitizer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Sanofi DUSA Pharmaceuticals Bausch Health Beiersdorf Soligenix Theralase Technologies Quest...

    • ◆H&Iグローバルリサーチのお客様（例）◆